Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Inulin

Research Leaders

6 sponsors active, led by Louis Stokes VA Medical Center

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Completed2
Unknown1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT05866393Not ApplicableCompletedPrimary

Clean Hands Accessible and Manageable for Patients (CHAMPs)

NCT03865706Phase 2Completed

Inulin for Infections in the Intensive Care Unit

NCT03491020WithdrawnPrimary

Emission Patterns of Respiratory Pathogens

NCT04264715Not ApplicableUnknownPrimary

Evaluation of the Impact of Germicidal Light (Indigo-Clean) on Intraoperative S. Aureus Exposure

Showing all 4 trials

Research Network

Common Treatments

  • Inulin1
  • Broadspectrum Antibiotics1
  • 405nm Light1
  • Clean Hands Accessible And Manageable For Patients1

Active Sponsors

  • Louis Stokes VA Medical Center1
  • Northwestern Medicine1
  • Columbia University1
  • MetroHealth Medical Center1
  • Case Western Reserve University1

Top Investigators

Related Conditions

  • Patient Participation1
  • Sepsis1
  • Nutrition Disorders1
  • Critical Illness1
  • Aging1

Activity Timeline